These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 30154116)
21. The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review. Ratten LK; Plummer EL; Bradshaw CS; Fairley CK; Murray GL; Garland SM; Bateson D; Tachedjian G; Masson L; Vodstrcil LA Front Cell Infect Microbiol; 2021; 11():732423. PubMed ID: 34869054 [TBL] [Abstract][Full Text] [Related]
22. The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV Acquisition. Thurman A; Chandra N; Schwartz JL; Brache V; Chen BA; Asin S; Rollenhagen C; Herold BC; Fichorova RN; Hillier SL; Weiner DH; Mauck C; Doncel GF AIDS Res Hum Retroviruses; 2019 Sep; 35(9):853-864. PubMed ID: 30997816 [TBL] [Abstract][Full Text] [Related]
23. Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice. Wessels JM; Nguyen PV; Vitali D; Mueller K; Vahedi F; Felker AM; Dupont HA; Bagri P; Verschoor CP; Deshiere A; Mazzulli T; Tremblay MJ; Ashkar AA; Kaushic C Sci Rep; 2021 Feb; 11(1):3894. PubMed ID: 33594113 [TBL] [Abstract][Full Text] [Related]
24. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. Doerflinger SY; Throop AL; Herbst-Kralovetz MM J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560 [TBL] [Abstract][Full Text] [Related]
25. Understanding mucosal and microbial functionality of the female reproductive tract by metaproteomics: Implications for HIV transmission. Berard AR; Perner M; Mutch S; Farr Zuend C; McQueen P; Burgener AD Am J Reprod Immunol; 2018 Aug; 80(2):e12977. PubMed ID: 29790240 [TBL] [Abstract][Full Text] [Related]
26. The vaginal microbiome amplifies sex hormone-associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption. Bradley F; Birse K; Hasselrot K; Noël-Romas L; Introini A; Wefer H; Seifert M; Engstrand L; Tjernlund A; Broliden K; Burgener AD Am J Reprod Immunol; 2018 Jul; 80(1):e12863. PubMed ID: 29709092 [TBL] [Abstract][Full Text] [Related]
27. Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections. Brotman RM; Ravel J; Bavoil PM; Gravitt PE; Ghanem KG Vaccine; 2014 Mar; 32(14):1543-52. PubMed ID: 24135572 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis. Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU Front Immunol; 2021; 12():760504. PubMed ID: 34956191 [TBL] [Abstract][Full Text] [Related]
29. Prevotella timonensis Bacteria Associated With Vaginal Dysbiosis Enhance Human Immunodeficiency Virus Type 1 Susceptibility Of Vaginal CD4+ T Cells. van Teijlingen NH; van Smoorenburg MY; Sarrami-Forooshani R; Zijlstra-Willems EM; van Hamme JL; Borgdorff H; van de Wijgert JHHM; van Leeuwen E; van der Post JAM; Strijbis K; Ribeiro CMS; Geijtenbeek TBH J Infect Dis; 2024 Jul; 230(1):e43-e47. PubMed ID: 39052703 [TBL] [Abstract][Full Text] [Related]
30. The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women. Abdool Karim SS; Baxter C; Passmore JS; McKinnon LR; Williams BL J Int AIDS Soc; 2019 May; 22(5):e25300. PubMed ID: 31144462 [TBL] [Abstract][Full Text] [Related]
31. Impact of reproductive aging on the vaginal microbiome and soluble immune mediators in women living with and at-risk for HIV infection. Murphy K; Keller MJ; Anastos K; Sinclair S; Devlin JC; Shi Q; Hoover DR; Starkman B; McGillick J; Mullis C; Minkoff H; Dominguez-Bello MG; Herold BC PLoS One; 2019; 14(4):e0216049. PubMed ID: 31026271 [TBL] [Abstract][Full Text] [Related]
32. The effect of menopause on the innate antiviral activity of cervicovaginal lavage. Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668 [TBL] [Abstract][Full Text] [Related]
34. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230 [TBL] [Abstract][Full Text] [Related]
35. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Quispe Calla NE; Vicetti Miguel RD; Boyaka PN; Hall-Stoodley L; Kaur B; Trout W; Pavelko SD; Cherpes TL Mucosal Immunol; 2016 Nov; 9(6):1571-1583. PubMed ID: 27007679 [TBL] [Abstract][Full Text] [Related]
36. Human vaginal microbiota colonization is regulated by female sex hormones in a mouse model. Rahman N; Mian MF; Nazli A; Kaushic C Front Cell Infect Microbiol; 2023; 13():1307451. PubMed ID: 38156321 [TBL] [Abstract][Full Text] [Related]
37. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. Bunjun R; Ramla TF; Jaumdally SZ; Noël-Romas L; Ayele H; Brown BP; Gamieldien H; Harryparsad R; Dabee S; Nair G; Onono M; Palanee-Phillips T; Scoville CW; Heller KB; Baeten JM; Bosinger SE; Burgener A; Passmore JS; Jaspan H; Heffron R Clin Infect Dis; 2022 Nov; 75(11):2000-2011. PubMed ID: 35941737 [TBL] [Abstract][Full Text] [Related]
38. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. Mitchell CM; McLemore L; Westerberg K; Astronomo R; Smythe K; Gardella C; Mack M; Magaret A; Patton D; Agnew K; McElrath MJ; Hladik F; Eschenbach D J Infect Dis; 2014 Aug; 210(4):651-5. PubMed ID: 24652495 [TBL] [Abstract][Full Text] [Related]
39. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. van de Wijgert JH; Verwijs MC; Turner AN; Morrison CS AIDS; 2013 Aug; 27(13):2141-53. PubMed ID: 23660575 [TBL] [Abstract][Full Text] [Related]
40. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]